Clinical Trial

Urinary Chloride and Sodium Changes and Residual Congestion in Acute Heart Failure

Study acronym: CLORINA-IC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn how changes in urinary sodium and chloride levels relate to fluid overload and short-term outcomes in patients hospitalized with acute heart failure (AHF). The main questions it aims to answer are: * Do changes over time in urinary sodium and chloride reflect how well excess fluid is being removed during hospitalization? * Are these changes associated with residual congestion at discharge and with the risk of worsening heart failure or death after discharge? Participants hospitalized for AHF and treated with intravenous diuretics as part of their usual care will have clinical assessments, blood and urine tests, and echocardiographic evaluations collected at several time points during their hospital stay. Researchers will also record clinical outcomes, including worsening heart failure or death, at 30 days and 3 months after discharge.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-13.
Trial Details
NCT Number NCT07597512
Lead Sponsor Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Collaborators: Carlos III Health Institute
Conditions Acute Heart Failure (AHF), Heart Failure, Congestion
Enrollment 223 participants
Start Date 2026-05
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-22